| |
Remark |
 G Protein-coupled receptors
|
Rhodopsin family
|
 Acetylcholine (muscarinic)
|
Adrenaline
|
Dopamine
|
Histamine
|
H1-receptor [HSA:3269] [KO:K04149]
|
H2-receptor [HSA:3274] [KO:K04150]
|
Cimetidine [DG:DG00017]
|
Ranitidine [DG:DG00018]
|
 D00422 Ranitidine (USAN/INN)
D00673 Ranitidine hydrochloride (JP17/USP)
|
Antagonist
Antagonist
|
Roxatidine [DG:DG00019]
|
Oxmetidine [DG:DG01225]
|
Asenapine
|
Dalcotidine
|
Donetidine
|
Etintidine
|
Famotidine
|
Histamine
|
Icotidine
|
Impromidine
|
Lafutidine
|
Lavoltidine
|
Lupitidine
|
Metiamide
|
Niperotidine
|
Nizatidine
|
Osutidine
|
Pibutidine
|
Ranitidine bismuth citrate
|
Sufotidine
|
Tiotidine
|
Zaltidine
|
H3-receptor [HSA:11255] [KO:K04151]
|
H4-receptor [HSA:59340] [KO:K04152]
|
Serotonin
|
Tachykinin / neurokinin
|
Ghrelin
|
Orexin
|
Neuropeptide Y
|
Opioid
|
Angiotensin
|
Bradykinin
|
Endothelin
|
Lutropin-choriogonadotropic hormone
|
Follicle stimulating hormone
|
Oxytocin
|
Vasopressin
|
Melanocortin
|
Gonadotropin-releasing hormone
|
Somatostatin
|
Thyrotropin-releasing hormone
|
Cholecystokinin
|
Motilin
|
Thrombin
|
Purine / pyrimidine
|
Adenosine
|
Prostaglandin
|
Prostacyclin
|
Leukotriene
|
Thromboxane
|
Sphingolipid
|
Free fatty acid
|
Cannabinoid
|
Platelet activating factor
|
Melatonin
|
Cysteinyl leukotriene
|
Secretin receptor family
|
Metabotropic glutamate receptor family
|
Others
|
|
|
Cytokine receptors
|
|
|
Nuclear receptors
|
|
|
Ion channels
|
|
|
Transporters
|
|
|
Enzymes
|
|
|
Protein kinases
|
|
|
Cytokines
|
|
|
Others
|
Target-based Classification of Drugs